Luban Therapeutics Private Limited - Company Profile

It is a trading private limited company based in Thane, Maharashtra, India, established in 2015.
2015 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Luban Therapeutics Private Limited

Luban Therapeutics Private Limited, a active private limited company, was established on 01 October 2015 in Thane, Maharashtra, India. Engaging in other wholesale within the trading sector, it holds CIN: U74999MH2015PTC268878. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sandeep Harijan Siddhu (Additional Director), Radhika Shrikrishna Shetye (Additional Director). Past directors included Amit Ganesh Tripathi, Devendra Yogendra Mishra. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Shop No-D-132, Jay-Vijay Nagari Ph-1, Near Riddhi -Vinayak Hospital, Nalasopara (W),, Thane, Maharashtra, 401203.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2015PTC268878

  • Registration Number

    268878

  • Incorporation Date

    01 October 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** 14288.50%
  • Profit Growth **** 10.32%
  • Ebitda **** 370.46%
  • Net Worth -38.75%
  • Total Assets **** 36.96%
Company report

Luban Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Luban Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Luban Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sandeep Harijan Siddhu Additional Director 18 Sep 2018 Current
Radhika Shrikrishna Shetye Additional Director 11 Dec 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Feb 2024 Past
Pramod Abcsdd Director 15 Jan 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Luban Therapeutics.

Luban Therapeutics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14288.5% increase. The company also saw a substantial improvement in profitability, with a 10.32% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.75%.

Luban Therapeutics revenue growth over time
Luban Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14288.50%
*******
*******
*******
*******
Revenue from Operations
*******
 14288.50%
*******
*******
*******
*******
Total Assets
*******
 36.96%
*******
*******
*******
*******
Profit or Loss
*******
 10.32%
*******
*******
*******
*******
Net Worth
*******
 -38.75%
*******
*******
*******
*******
EBITDA
*******
 370.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Luban Therapeutics?

In 2017, Luban Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Luban Therapeutics?

Unlock and access historical data on people associated with Luban Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Luban Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Luban Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Luban Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Luban Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Luban Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai Ii. was completed.

  • Director Appointment

    Radhika Shrikrishna Shetye was appointed as a Additional Director was appointed as a Additional Director on 11 Dec 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sandeep Harijan Siddhu was appointed as a Additional Director was appointed as a Additional Director on 18 Sep 2018 & has been associated with this company since 7 years 6 months . was documented.

  • Company Incorporation

    Progress on Luban Therapeutics Private Limited was registered on 01 Oct 2015 with Roc Mumbai Ii & aged 10 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Luban Therapeutics Private Limited?

The CIN of Luban Therapeutics Private Limited is U74999MH2015PTC268878.

Where is Luban Therapeutics Private Limited headquartered?

Luban Therapeutics Private Limited is headquartered at Shop No-D-132, Jay-Vijay Nagari Ph-1, Near Riddhi -Vinayak Hospital, Nalasopara (W),, Thane, Maharashtra, 401203.

When was Luban Therapeutics Private Limited incorporated?

Luban Therapeutics Private Limited was incorporated on 01 October 2015.

Who are the current directors of Luban Therapeutics Private Limited?

The current directors of Luban Therapeutics Private Limited are

What is the primary industry of Luban Therapeutics Private Limited?

The primary industry of Luban Therapeutics Private Limited is Trading.

Is Luban Therapeutics Private Limited a listed company?

Luban Therapeutics Private Limited is unlisted.

What is the capital structure of Luban Therapeutics Private Limited?

The authorized capital of Luban Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Luban Therapeutics Private Limited?

The compliance status of Luban Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available